je.st
news
Home
› DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
2013-06-04 09:45:49| Logistics - Topix.net
Activity with VAL-083 Observed in Recurrent Malignant Glioma and Progressive Secondary Brain Tumors Company Plans to Expand Clinical Development of VAL-083 /PRNewswire/ -- DelMar Pharmaceuticals, Inc.
Tags: data
additional
study
cancer
Category:Transportation and Logistics